VEGFR3 does not sustain retinal angiogenesis without VEGFR2

Proceedings of the National Academy of Sciences of the United States of America

Volumn 112, Issue 3, 2015, Pages 761-766

  Zarkada, Georgia ^a   Heinolainen, Krista ^a   Makinen, Taija ^b,c   Kubota, Yoshiaki ^d   Alitalo, Kari ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^c UPPSALA UNIVERSITY   (Sweden)

^d KEIO UNIVERSITY   (Japan)

Author keywords

Anti angiogenesis; Lymphangiogenesis; Notch; VEGFC; VEGFD

Indexed keywords

DELTA LIKE LIGAND 4; GAMMA SECRETASE INHIBITOR; MEMBRANE PROTEIN; N [ N ( 3,5 DIFLUOROPHENACETYL)ALANYL]PHENYGLYCINE TERT BUTYL ESTER; NOTCH RECEPTOR; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN RECEPTOR 3;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIANGIOGENIC ACTIVITY; ARTICLE; BLOOD VESSEL; CONTROLLED STUDY; GENE DELETION; GENE EXPRESSION; IN VIVO STUDY; LETHALITY; LYMPH VESSEL; LYMPHANGIOGENESIS; MOUSE; NEWBORN; NONHUMAN; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RECEPTOR UPREGULATION; RETINA; SIGNAL TRANSDUCTION; SPROUTING; VASCULAR ENDOTHELIUM; ANIMAL; GROWTH, DEVELOPMENT AND AGING; PHYSIOLOGY; RETINA BLOOD VESSEL;

ANIMALS; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; RETINAL VESSELS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3;

EID: 84921417379     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1423278112     Document Type: Article

References (40)

1. Koch S, Claesson-Welsh L (2012) Signal transduction by vascular endothelial growth factor receptors. Cold Spring Harb Perspect Med 2(7):a006502.
2. Shalaby F, et al. (1995) Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376(6535):62-66.
3. Shojaei F, Ferrara N (2007) Antiangiogenesis to treat cancer and intraocular neovascular disorders. Lab Invest 87(3):227-230.
4. Dumont DJ, et al. (1998) Cardiovascular failure in mouse embryos deficient in VEGF receptor-3. Science 282(5390):946-949.
5. Kaipainen A, et al. (1995) Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci USA 92(8):3566-3570.
6. Partanen TA, et al. (2000) VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor, VEGFR-3, in fenestrated blood vessels in human tissues. FASEB J 14(13): 2087-2096.
7. Tammela T, et al. (2008) Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation. Nature 454(7204):656-660.
8. Siekmann AF, Lawson ND (2007) Notch signalling limits angiogenic cell behaviour in developing zebrafish arteries. Nature 445(7129):781-784.
9. Valtola R, et al. (1999) VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer. Am J Pathol 154(5):1381-1390.
10. Paavonen K, Puolakkainen P, Jussila L, Jahkola T, Alitalo K (2000) Vascular endothelial growth factor receptor-3 in lymphangiogenesis in wound healing. Am J Pathol 156(5): 1499-1504.
11. Herbert SP, Stainier DY (2011) Molecular control of endothelial cell behaviour during blood vessel morphogenesis. Nat Rev Mol Cell Biol 12(9):551-564.
12. Lobov IB, et al. (2007) Delta-like ligand 4 (Dll4) is induced by VEGF as a negative regulator of angiogenic sprouting. Proc Natl Acad Sci USA 104(9):3219-3224.
13. Suchting S, et al. (2007) The Notch ligand Delta-like 4 negatively regulates endothelial tip cell formation and vessel branching. Proc Natl Acad Sci USA 104(9):3225-3230.
14. Jakobsson L, et al. (2010) Endothelial cells dynamically compete for the tip cell position during angiogenic sprouting. Nat Cell Biol 12(10):943-953.
15. Patel NS, et al. (2005) Up-regulation of delta-like 4 ligand in human tumor vasculature and the role of basal expression in endothelial cell function. Cancer Res 65(19): 8690-8697.
16. Tammela T, et al. (2011) VEGFR-3 controls tip to stalk conversion at vessel fusion sites by reinforcing Notch signalling. Nat Cell Biol 13(10):1202-1213.
17. Shawber CJ, et al. (2007) Notch alters VEGF responsiveness in human and murine endothelial cells by direct regulation of VEGFR-3 expression. J Clin Invest 117(11): 3369-3382.
18. Covassin LD, Villefranc JA, Kacergis MC, Weinstein BM, Lawson ND (2006) Distinct genetic interactions between multiple Vegf receptors are required for development of different blood vessel types in zebrafish. Proc Natl Acad Sci USA 103(17): 6554-6559.
19. Nilsson I, et al. (2010) VEGF receptor 2/-3 heterodimers detected in situ by proximity ligation on angiogenic sprouts. EMBO J 29(8):1377-1388.
20. Benedito R, et al. (2012) Notch-dependent VEGFR3 upregulation allows angiogenesis without VEGF-VEGFR2 signalling. Nature 484(7392):110-114.
21. Claxton S, et al. (2008) Efficient, inducible Cre-recombinase activation in vascular endothelium. Genesis 46(2):74-80.
22. Wang Y, et al. (2010) Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis. Nature 465(7297):483-486.
23. Haigh JJ, et al. (2003) Cortical and retinal defects caused by dosage-dependent reductions in VEGF-A paracrine signaling. Dev Biol 262(2):225-241.
24. Haiko P, et al. (2008) Deletion of vascular endothelial growth factor C (VEGF-C) and VEGF-D is not equivalent to VEGF receptor 3 deletion in mouse embryos. Mol Cell Biol 28(15):4843-4850.
25. Waltenberger J, Claesson-Welsh L, Siegbahn A, Shibuya M, Heldin CH (1994) Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J Biol Chem 269(43):26988-26995.
26. Gerhardt H, et al. (2003) VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J Cell Biol 161(6):1163-1177.
27. Lawson ND, et al. (2001) Notch signaling is required for arterial-venous differentiation during embryonic vascular development. Development 128(19):3675-3683.
28. Duarte A, et al. (2004) Dosage-sensitive requirement for mouse Dll4 in artery development. Genes Dev 18(20):2474-2478.
29. Swift MR, Weinstein BM (2009) Arterial-venous specification during development. Circ Res 104(5):576-588.
30. Hooper AT, et al. (2009) Engraftment and reconstitution of hematopoiesis is dependent on VEGFR2-mediated regeneration of sinusoidal endothelial cells. Cell Stem Cell 4(3):263-274.
31. Okabe K, et al. (2014) Neurons limit angiogenesis by titrating VEGF in retina. Cell 159(3):584-596.
32. Hozumi K, et al. (2008) Delta-like 4 is indispensable in thymic environment specific for T cell development. J Exp Med 205(11):2507-2513.
33. Hellström M, et al. (2007) Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis. Nature 445(7129):776-780.
34. Phng LK, Gerhardt H (2009) Angiogenesis: A team effort coordinated by notch. Dev Cell 16(2):196-208.
35. Sivaraj KK, et al. (2013) G13 controls angiogenesis through regulation of VEGFR-2 expression. Dev Cell 25(4):427-434.
36. Yang X, Cepko CL (1996) Flk-1, a receptor for vascular endothelial growth factor (VEGF), is expressed by retinal progenitor cells. J Neurosci 16(19):6089-6099.
37. Gale NW, et al. (2004) Haploinsufficiency of delta-like 4 ligand results in embryonic lethality due to major defects in arterial and vascular development. Proc Natl Acad Sci USA 101(45):15949-15954.
38. Stenzel D, et al. (2011) Endothelial basement membrane limits tip cell formation by inducing Dll4/Notch signalling in vivo. EMBO Rep 12(11):1135-1143.
39. Estrach S, et al. (2011) Laminin-binding integrins induce Dll4 expression and Notch signaling in endothelial cells. Circ Res 109(2):172-182.
40. Sainson RC, et al. (2005) Cell-autonomous notch signaling regulates endothelial cell branching and proliferation during vascular tubulogenesis. FASEB J 19(8):1027-1029.